See the DrugPatentWatch profile for Daliresp
What is Daliresp, and what is it used for?
Daliresp is the brand name for roflumilast, a prescription medicine used for chronic obstructive pulmonary disease (COPD). It is intended for people with COPD who have chronic bronchitis and a history of frequent exacerbations (flare-ups) to help reduce exacerbations. [1]
How does Daliresp work in COPD?
Roflumilast works by reducing inflammation in the airways. It is a phosphodiesterase-4 (PDE4) inhibitor, which helps lower inflammatory signaling that contributes to COPD symptoms and flare-ups. [1]
Who can take Daliresp, and who should avoid it?
Daliresp is prescribed for specific COPD patients (typically those with chronic bronchitis and frequent exacerbations). People with certain risk factors may need extra caution because roflumilast can worsen psychiatric symptoms and may cause gastrointestinal side effects. Your clinician will consider your medical history and other medications. [1]
What side effects do people ask about most?
Commonly reported side effects include gastrointestinal symptoms such as diarrhea, nausea, and weight loss, along with headache and insomnia. Because weight loss can be significant for some patients, clinicians monitor weight during treatment. [1]
How is Daliresp taken?
Daliresp is taken by mouth once daily. The prescribed dose depends on the product strength and your clinician’s instructions. [1]
When does Daliresp start to work?
Daliresp is used to reduce the number of COPD exacerbations over time rather than to act like a rescue inhaler during sudden breathing trouble. The full benefit typically takes weeks of consistent use and follow-up. [1]
Can Daliresp be combined with inhalers?
Clinicians commonly use roflumilast alongside inhaled COPD maintenance therapies (like inhaled corticosteroids, long-acting beta agonists, and/or long-acting muscarinic antagonists) for patients who still have frequent exacerbations despite inhaler therapy. The exact regimen depends on your COPD severity and symptom history. [1]
What interactions should patients watch for?
Roflumilast can interact with other drugs that affect liver metabolism, which may change roflumilast levels or side-effect risk. Always review your full medication list with your pharmacist or prescriber. [1]
How does Daliresp compare with other COPD “anti-exacerbation” options?
Unlike inhalers used to prevent and control symptoms, Daliresp targets exacerbation risk through an oral anti-inflammatory mechanism (PDE4 inhibition). Other exacerbation-prevention approaches depend on COPD phenotype and may include inhaled therapies, oxygen for low oxygen levels, smoking cessation, and in some cases other targeted medications. [1]
Is there a generic version, and what does that mean for cost?
Daliresp’s active ingredient is roflumilast. Whether a generic is available and pricing depends on country and pharmacy pricing. If you’re trying to lower cost, ask your pharmacist about generics and prescription-assistance programs. [1]
Sources
[1] https://www.daliresp.com/ (Daliresp prescribing information/product information)